<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Aptos;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Aptos",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#467886;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
font-size:11.0pt;
font-family:"Aptos",sans-serif;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;
mso-ligatures:none;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#467886" vlink="#96607D" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal" align="center" style="text-align:center"><b><i><span style="font-family:"Arial",sans-serif;color:#C00000">~~ Please disseminate this information with those researchers and research administrators in your department who may find it noteworthy
~~<span style="mso-ligatures:standardcontextual"><o:p></o:p></span></span></i></b></p>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:12.0pt;color:#002060"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:#002060"><o:p> </o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center"><b><span style="font-size:16.0pt;color:#20558A">UPDATE: TEMPORARY RESTRAINING ORDER GRANTED RE</span></b><b><span style="font-size:16.0pt">:<span style="color:#20558A"> NIH NOTICE NOT-OD-25-068</span></span></b><b><span style="font-family:"Arial",sans-serif;color:#20558A"><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><i><span style="color:#002060"><o:p> </o:p></span></i></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">On Friday, February 7, 2025, the National Institutes of Health (NH) issued
<a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-068.html">NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates</a>. As a result, UCR provided the campus with NIH proposal submission guidance
yesterday. Thereafter, the court granted two separate temporary restraining orders (see
<a href="https://storage.courtlistener.com/recap/gov.uscourts.mad.280590/gov.uscourts.mad.280590.25.0.pdf">
Civil Action No. 25-CV-10338-AK</a> and</span><span style="font-size:12.0pt;color:black">
</span><span style="font-size:12.0pt"><a href="https://e.ropesgray.com/collect/click.aspx?u=V0FQNGhvMGtjbnlkOXVLM01LK2ZUT3o3d2RZZytQTk5WWlY5VjlRcG1uNkI2dmFGM1BPTkRjUjlES1F2WmtNYmpWTFprK3JZd2VEVjIyNzltWmU4NkNMUnhPcnd3UExGTUVxK050Nlp6TXNlSnFXY0VpVy9YVDhVRGwzZzZoK2hNa3lxWmZwSW1WMnN2RTF6QjhNVE9Ta2liQjhySERLT1BLblVuRUkyUXNlRXBxNnBaOExGU0w4aG5FeUpEYzZC&rh=ff00e0ea621fa0fa3a7c186e1e409606c519609f" target="_blank">Civil
Action No. 25-CV-10340-AK</a>) </span><span style="font-size:12.0pt">which prohibit NIH
<span style="color:black">from taking any steps to implement, apply, or enforce the NOT-OD-25-068 until further order is issued by the Court.
<o:p></o:p></span></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:black">The </span><span style="font-size:12.0pt">office Research and Economic Development now provides the following updated NIH proposal submission guidance:
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt">NIH Proposal Submissions - UPDATE</span></b><span style="font-size:12.0pt"><o:p></o:p></span></p>
<p class="MsoListParagraph" style="margin-left:0in"><span style="font-size:12.0pt;color:#20558A">For NIH proposal submissions, principal investigators are advised to utilize the IDC rates currently approved in UCR’s Federally Negotiated Indirect Cost Rate Agreement
(NICRA) dated April 9, 2024, until further notice. Contrary to yesterday’s guidance, please NOT include the disclaimer language addressing NOT-OD-25-068 in the Budget Justification.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:#20558A"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">RED will provide further information as circumstances evolve. Should you have any questions or concerns, please contact
<a href="mailto:REDalert@ucr.edu">REDalert@ucr.edu</a>.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>